Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.25014437 |
2 | synaptic vesicle maturation (GO:0016188) | 5.80083331 |
3 | locomotory exploration behavior (GO:0035641) | 5.73086633 |
4 | glutamate secretion (GO:0014047) | 5.69774374 |
5 | synaptic vesicle exocytosis (GO:0016079) | 5.67551967 |
6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.66887636 |
7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.58981650 |
8 | vocalization behavior (GO:0071625) | 5.52464646 |
9 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.51308293 |
10 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.19356992 |
11 | protein localization to synapse (GO:0035418) | 5.16368561 |
12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.09070521 |
13 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.08333466 |
14 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.05729924 |
15 | neuronal action potential propagation (GO:0019227) | 4.87763180 |
16 | neuron cell-cell adhesion (GO:0007158) | 4.85163619 |
17 | exploration behavior (GO:0035640) | 4.73239590 |
18 | glutamate receptor signaling pathway (GO:0007215) | 4.69059975 |
19 | regulation of synaptic vesicle transport (GO:1902803) | 4.61795625 |
20 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.59695581 |
21 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.59474630 |
22 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.53778060 |
23 | synaptic transmission, glutamatergic (GO:0035249) | 4.39864827 |
24 | L-amino acid import (GO:0043092) | 4.39787372 |
25 | neurotransmitter secretion (GO:0007269) | 4.30800257 |
26 | layer formation in cerebral cortex (GO:0021819) | 4.21156668 |
27 | neuronal ion channel clustering (GO:0045161) | 4.09342131 |
28 | neuron-neuron synaptic transmission (GO:0007270) | 4.08602738 |
29 | positive regulation of synapse maturation (GO:0090129) | 4.06702581 |
30 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.05386646 |
31 | neuron recognition (GO:0008038) | 4.04628471 |
32 | dendritic spine morphogenesis (GO:0060997) | 4.02812825 |
33 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.00921318 |
34 | amino acid import (GO:0043090) | 3.99443212 |
35 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.98934239 |
36 | proline transport (GO:0015824) | 3.97129021 |
37 | long-term memory (GO:0007616) | 3.96996004 |
38 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.95940865 |
39 | cellular potassium ion homeostasis (GO:0030007) | 3.93060742 |
40 | potassium ion homeostasis (GO:0055075) | 3.91501379 |
41 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.90637438 |
42 | regulation of synapse structural plasticity (GO:0051823) | 3.85726044 |
43 | regulation of synaptic plasticity (GO:0048167) | 3.85709937 |
44 | regulation of postsynaptic membrane potential (GO:0060078) | 3.85112985 |
45 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.80942215 |
46 | synaptic vesicle endocytosis (GO:0048488) | 3.79644632 |
47 | positive regulation of membrane potential (GO:0045838) | 3.78432098 |
48 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.76784136 |
49 | axonal fasciculation (GO:0007413) | 3.72453478 |
50 | long-term synaptic potentiation (GO:0060291) | 3.68990125 |
51 | gamma-aminobutyric acid transport (GO:0015812) | 3.58940925 |
52 | axon ensheathment in central nervous system (GO:0032291) | 3.57890400 |
53 | central nervous system myelination (GO:0022010) | 3.57890400 |
54 | regulation of neurotransmitter secretion (GO:0046928) | 3.57333133 |
55 | potassium ion import (GO:0010107) | 3.55301218 |
56 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.52804062 |
57 | neurotransmitter transport (GO:0006836) | 3.52687777 |
58 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.51769830 |
59 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.50471215 |
60 | regulation of vesicle fusion (GO:0031338) | 3.49796018 |
61 | auditory behavior (GO:0031223) | 3.46412228 |
62 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.45634129 |
63 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.45177678 |
64 | postsynaptic membrane organization (GO:0001941) | 3.44611940 |
65 | neuromuscular synaptic transmission (GO:0007274) | 3.41007266 |
66 | activation of protein kinase A activity (GO:0034199) | 3.38377303 |
67 | sodium ion export (GO:0071436) | 3.36572285 |
68 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.36458428 |
69 | regulation of dendritic spine development (GO:0060998) | 3.34696927 |
70 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.31557092 |
71 | presynaptic membrane assembly (GO:0097105) | 3.30057589 |
72 | regulation of ARF protein signal transduction (GO:0032012) | 3.29514033 |
73 | positive regulation of dendritic spine development (GO:0060999) | 3.28838518 |
74 | behavioral defense response (GO:0002209) | 3.28745195 |
75 | behavioral fear response (GO:0001662) | 3.28745195 |
76 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.28481015 |
77 | transmission of nerve impulse (GO:0019226) | 3.28421693 |
78 | dendritic spine organization (GO:0097061) | 3.27028999 |
79 | establishment of synaptic vesicle localization (GO:0097480) | 3.27024649 |
80 | synaptic vesicle transport (GO:0048489) | 3.27024649 |
81 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.26966604 |
82 | innervation (GO:0060384) | 3.24787246 |
83 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.24603248 |
84 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.24045185 |
85 | establishment of mitochondrion localization (GO:0051654) | 3.23062433 |
86 | membrane depolarization (GO:0051899) | 3.22960311 |
87 | regulation of neurotransmitter levels (GO:0001505) | 3.22367013 |
88 | fear response (GO:0042596) | 3.19463298 |
89 | neuromuscular process controlling balance (GO:0050885) | 3.18587492 |
90 | regulation of neurotransmitter transport (GO:0051588) | 3.18487175 |
91 | cellular sodium ion homeostasis (GO:0006883) | 3.17574002 |
92 | acidic amino acid transport (GO:0015800) | 3.17005977 |
93 | cell communication by electrical coupling (GO:0010644) | 3.15166629 |
94 | neuromuscular process controlling posture (GO:0050884) | 3.14030622 |
95 | neurotransmitter uptake (GO:0001504) | 3.13458891 |
96 | regulation of synaptic transmission (GO:0050804) | 3.12555214 |
97 | regulation of synapse maturation (GO:0090128) | 3.11411394 |
98 | response to histamine (GO:0034776) | 3.10132608 |
99 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.08771195 |
100 | dendrite morphogenesis (GO:0048813) | 3.08324195 |
101 | cerebellar granule cell differentiation (GO:0021707) | 3.07608146 |
102 | positive regulation of neurotransmitter transport (GO:0051590) | 3.07583555 |
103 | learning (GO:0007612) | 3.07414065 |
104 | vesicle docking involved in exocytosis (GO:0006904) | 3.06433454 |
105 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.05828419 |
106 | neuromuscular process (GO:0050905) | 3.05433685 |
107 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.05069566 |
108 | presynaptic membrane organization (GO:0097090) | 3.04672310 |
109 | synaptic transmission (GO:0007268) | 3.03390707 |
110 | membrane depolarization during action potential (GO:0086010) | 3.01319671 |
111 | positive regulation of synaptic transmission (GO:0050806) | 3.00151487 |
112 | long term synaptic depression (GO:0060292) | 2.97022617 |
113 | detection of calcium ion (GO:0005513) | 2.96472380 |
114 | vesicle transport along microtubule (GO:0047496) | 2.95022535 |
115 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.93922754 |
116 | intraspecies interaction between organisms (GO:0051703) | 2.93711858 |
117 | social behavior (GO:0035176) | 2.93711858 |
118 | synapse assembly (GO:0007416) | 2.89734192 |
119 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.87310641 |
120 | membrane hyperpolarization (GO:0060081) | 2.87055896 |
121 | cell migration in hindbrain (GO:0021535) | 2.87053826 |
122 | chemosensory behavior (GO:0007635) | 2.85399907 |
123 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.83345313 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.58925426 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.63180642 |
3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.25447892 |
4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.23444822 |
5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.15516948 |
6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.86428551 |
7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.86428551 |
8 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.78609054 |
9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.77319574 |
10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.75422070 |
11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.64359958 |
12 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.58375554 |
13 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.56253811 |
14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.55832538 |
15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.55652040 |
16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.55408175 |
17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.42527945 |
18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.38038064 |
19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.28908246 |
20 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.27281552 |
21 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.27134482 |
22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.25794361 |
23 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.22436230 |
24 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.95668263 |
25 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.91008158 |
26 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.90649166 |
27 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.90102692 |
28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.89227714 |
29 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.77419425 |
30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.76250029 |
31 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.74493519 |
32 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.71380037 |
33 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.65641345 |
34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.64957694 |
35 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.59836709 |
36 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.54623508 |
37 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.53134162 |
38 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.45863099 |
39 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.44757026 |
40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.40558271 |
41 | P300_19829295_ChIP-Seq_ESCs_Human | 1.40471240 |
42 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.38991291 |
43 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.37150861 |
44 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.32195125 |
45 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.31419500 |
46 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.30054506 |
47 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29793193 |
48 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.28363656 |
49 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.27559371 |
50 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.27218020 |
51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.25865900 |
52 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25862917 |
53 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.25858448 |
54 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.25575258 |
55 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.24839286 |
56 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24326257 |
57 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.23968764 |
58 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.23730206 |
59 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.21613327 |
60 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.19314472 |
61 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.17202050 |
62 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.16885369 |
63 | STAT3_23295773_ChIP-Seq_U87_Human | 1.16295775 |
64 | * AR_19668381_ChIP-Seq_PC3_Human | 1.16223499 |
65 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15336364 |
66 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.13284309 |
67 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13232960 |
68 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.13178274 |
69 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11508069 |
70 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.11442224 |
71 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09961653 |
72 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09841470 |
73 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.07895395 |
74 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.07750600 |
75 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07522466 |
76 | VDR_22108803_ChIP-Seq_LS180_Human | 1.05574459 |
77 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04964177 |
78 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.04373390 |
79 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.04077414 |
80 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.03730465 |
81 | KDM2B_26808549_Chip-Seq_K562_Human | 1.01726886 |
82 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.01579248 |
83 | TCF4_23295773_ChIP-Seq_U87_Human | 1.01120121 |
84 | FUS_26573619_Chip-Seq_HEK293_Human | 1.01089853 |
85 | TP53_16413492_ChIP-PET_HCT116_Human | 1.00388228 |
86 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99474676 |
87 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.99321089 |
88 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99303472 |
89 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.99190468 |
90 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.98755129 |
91 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.98711907 |
92 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.98536702 |
93 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.97734827 |
94 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.96960962 |
95 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.96430027 |
96 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96430027 |
97 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.95014259 |
98 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.94491193 |
99 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94292811 |
100 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.93532525 |
101 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.93410826 |
102 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.93089328 |
103 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.91749758 |
104 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.91577922 |
105 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91422414 |
106 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.91302710 |
107 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.90760909 |
108 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.90743111 |
109 | JUN_21703547_ChIP-Seq_K562_Human | 0.90643374 |
110 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.90543600 |
111 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90465657 |
112 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90461700 |
113 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90196973 |
114 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.89173844 |
115 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.87995637 |
116 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.87721648 |
117 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.87616212 |
118 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86146199 |
119 | RXR_22108803_ChIP-Seq_LS180_Human | 0.85363960 |
120 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.82231844 |
121 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.78522373 |
122 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.74570698 |
123 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.74485839 |
124 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.74327829 |
125 | * SOX9_26525672_Chip-Seq_HEART_Mouse | 0.72576287 |
126 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.72142371 |
127 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.71890761 |
128 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.71435515 |
129 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.71362026 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 7.10945251 |
2 | MP0003880_abnormal_central_pattern | 5.36049142 |
3 | MP0003635_abnormal_synaptic_transmissio | 4.34491813 |
4 | MP0004270_analgesia | 3.88321960 |
5 | MP0009745_abnormal_behavioral_response | 3.51408514 |
6 | MP0002063_abnormal_learning/memory/cond | 3.51107655 |
7 | MP0002064_seizures | 3.24728651 |
8 | MP0001968_abnormal_touch/_nociception | 3.08643209 |
9 | MP0009046_muscle_twitch | 2.94978787 |
10 | MP0002572_abnormal_emotion/affect_behav | 2.88974930 |
11 | MP0002734_abnormal_mechanical_nocicepti | 2.64413331 |
12 | MP0002272_abnormal_nervous_system | 2.64148985 |
13 | MP0002735_abnormal_chemical_nociception | 2.54854452 |
14 | MP0005423_abnormal_somatic_nervous | 2.53989530 |
15 | MP0001486_abnormal_startle_reflex | 2.50152189 |
16 | MP0002736_abnormal_nociception_after | 2.46173897 |
17 | MP0001501_abnormal_sleep_pattern | 2.44338810 |
18 | MP0001440_abnormal_grooming_behavior | 2.36832718 |
19 | MP0003329_amyloid_beta_deposits | 2.17946514 |
20 | MP0002733_abnormal_thermal_nociception | 2.05766412 |
21 | MP0004858_abnormal_nervous_system | 2.03344218 |
22 | MP0002067_abnormal_sensory_capabilities | 1.98144971 |
23 | MP0001970_abnormal_pain_threshold | 1.97439134 |
24 | MP0002184_abnormal_innervation | 1.95742703 |
25 | MP0000778_abnormal_nervous_system | 1.94017058 |
26 | MP0002822_catalepsy | 1.93881030 |
27 | MP0009780_abnormal_chondrocyte_physiolo | 1.90528824 |
28 | MP0008569_lethality_at_weaning | 1.81240288 |
29 | MP0004811_abnormal_neuron_physiology | 1.75383029 |
30 | MP0001984_abnormal_olfaction | 1.72989205 |
31 | MP0003879_abnormal_hair_cell | 1.70362317 |
32 | MP0002557_abnormal_social/conspecific_i | 1.70112720 |
33 | MP0003123_paternal_imprinting | 1.66608737 |
34 | MP0006276_abnormal_autonomic_nervous | 1.63495269 |
35 | MP0004924_abnormal_behavior | 1.58744039 |
36 | MP0005386_behavior/neurological_phenoty | 1.58744039 |
37 | MP0000955_abnormal_spinal_cord | 1.57491163 |
38 | MP0002909_abnormal_adrenal_gland | 1.51101929 |
39 | MP0002882_abnormal_neuron_morphology | 1.45575918 |
40 | MP0002066_abnormal_motor_capabilities/c | 1.41935672 |
41 | MP0003787_abnormal_imprinting | 1.33639637 |
42 | MP0004885_abnormal_endolymph | 1.32306035 |
43 | MP0003633_abnormal_nervous_system | 1.31783393 |
44 | MP0001502_abnormal_circadian_rhythm | 1.27535411 |
45 | MP0005646_abnormal_pituitary_gland | 1.23196877 |
46 | MP0001905_abnormal_dopamine_level | 1.21106883 |
47 | MP0005645_abnormal_hypothalamus_physiol | 1.19280733 |
48 | MP0008877_abnormal_DNA_methylation | 1.16111164 |
49 | MP0003631_nervous_system_phenotype | 1.14399902 |
50 | MP0002152_abnormal_brain_morphology | 1.11416487 |
51 | MP0010386_abnormal_urinary_bladder | 1.09461529 |
52 | MP0004145_abnormal_muscle_electrophysio | 1.09237024 |
53 | MP0004142_abnormal_muscle_tone | 1.07993912 |
54 | MP0000604_amyloidosis | 1.07453148 |
55 | MP0004510_myositis | 1.03130831 |
56 | MP0003121_genomic_imprinting | 1.00286395 |
57 | MP0004742_abnormal_vestibular_system | 0.96386211 |
58 | MP0003122_maternal_imprinting | 0.94659686 |
59 | MP0000751_myopathy | 0.94221743 |
60 | MP0002229_neurodegeneration | 0.92956503 |
61 | MP0002837_dystrophic_cardiac_calcinosis | 0.92906504 |
62 | MP0002069_abnormal_eating/drinking_beha | 0.92388463 |
63 | MP0005551_abnormal_eye_electrophysiolog | 0.92305084 |
64 | MP0008872_abnormal_physiological_respon | 0.91324545 |
65 | MP0008874_decreased_physiological_sensi | 0.89463392 |
66 | MP0001188_hyperpigmentation | 0.88274706 |
67 | MP0001963_abnormal_hearing_physiology | 0.87604896 |
68 | MP0001529_abnormal_vocalization | 0.87332791 |
69 | MP0005394_taste/olfaction_phenotype | 0.87264410 |
70 | MP0005499_abnormal_olfactory_system | 0.87264410 |
71 | MP0004484_altered_response_of | 0.86273637 |
72 | MP0003632_abnormal_nervous_system | 0.82970483 |
73 | MP0005535_abnormal_body_temperature | 0.82754920 |
74 | MP0002752_abnormal_somatic_nervous | 0.80849208 |
75 | MP0001986_abnormal_taste_sensitivity | 0.78866800 |
76 | MP0002876_abnormal_thyroid_physiology | 0.78537598 |
77 | MP0004085_abnormal_heartbeat | 0.78285624 |
78 | MP0004147_increased_porphyrin_level | 0.77857435 |
79 | MP0003634_abnormal_glial_cell | 0.77488738 |
80 | MP0001346_abnormal_lacrimal_gland | 0.74319951 |
81 | MP0010234_abnormal_vibrissa_follicle | 0.74269850 |
82 | MP0001177_atelectasis | 0.73525700 |
83 | MP0008961_abnormal_basal_metabolism | 0.72682013 |
84 | MP0000569_abnormal_digit_pigmentation | 0.72173953 |
85 | MP0004215_abnormal_myocardial_fiber | 0.70933761 |
86 | MP0000920_abnormal_myelination | 0.68494282 |
87 | MP0001485_abnormal_pinna_reflex | 0.67299979 |
88 | MP0002090_abnormal_vision | 0.67189425 |
89 | MP0001664_abnormal_digestion | 0.65547637 |
90 | * MP0003075_altered_response_to | 0.65411624 |
91 | MP0000013_abnormal_adipose_tissue | 0.65173219 |
92 | MP0001348_abnormal_lacrimal_gland | 0.64588523 |
93 | MP0000579_abnormal_nail_morphology | 0.63851903 |
94 | MP0003283_abnormal_digestive_organ | 0.63620343 |
95 | MP0003690_abnormal_glial_cell | 0.63490558 |
96 | MP0000631_abnormal_neuroendocrine_gland | 0.60530727 |
97 | MP0006292_abnormal_olfactory_placode | 0.60133413 |
98 | MP0003861_abnormal_nervous_system | 0.58618621 |
99 | MP0004233_abnormal_muscle_weight | 0.58374852 |
100 | MP0005623_abnormal_meninges_morphology | 0.58166561 |
101 | MP0010768_mortality/aging | 0.54777436 |
102 | MP0002082_postnatal_lethality | 0.54521330 |
103 | MP0004130_abnormal_muscle_cell | 0.54112489 |
104 | MP0000026_abnormal_inner_ear | 0.53903698 |
105 | MP0002638_abnormal_pupillary_reflex | 0.52973520 |
106 | MP0003938_abnormal_ear_development | 0.52441452 |
107 | MP0005187_abnormal_penis_morphology | 0.52414060 |
108 | MP0002653_abnormal_ependyma_morphology | 0.51781923 |
109 | MP0003137_abnormal_impulse_conducting | 0.51445649 |
110 | MP0003956_abnormal_body_size | 0.51123093 |
111 | MP0001943_abnormal_respiration | 0.50999920 |
112 | MP0005167_abnormal_blood-brain_barrier | 0.50537028 |
113 | MP0010769_abnormal_survival | 0.50534783 |
114 | MP0002234_abnormal_pharynx_morphology | 0.49403089 |
115 | MP0000566_synostosis | 0.48824230 |
116 | MP0010770_preweaning_lethality | 0.48322455 |
117 | MP0001299_abnormal_eye_distance/ | 0.45881220 |
118 | MP0002873_normal_phenotype | 0.42491320 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 8.33187109 |
2 | Myokymia (HP:0002411) | 6.66142935 |
3 | Focal seizures (HP:0007359) | 6.20585623 |
4 | Visual hallucinations (HP:0002367) | 5.89626219 |
5 | Atonic seizures (HP:0010819) | 5.41410628 |
6 | Epileptic encephalopathy (HP:0200134) | 5.41069622 |
7 | Febrile seizures (HP:0002373) | 4.92840021 |
8 | Absence seizures (HP:0002121) | 4.72282320 |
9 | Dialeptic seizures (HP:0011146) | 4.38639931 |
10 | Progressive cerebellar ataxia (HP:0002073) | 4.33835633 |
11 | Generalized tonic-clonic seizures (HP:0002069) | 4.17854120 |
12 | Hyperventilation (HP:0002883) | 3.94447200 |
13 | Action tremor (HP:0002345) | 3.83381590 |
14 | Amblyopia (HP:0000646) | 3.79177148 |
15 | Supranuclear gaze palsy (HP:0000605) | 3.72223957 |
16 | Broad-based gait (HP:0002136) | 3.66106927 |
17 | Poor eye contact (HP:0000817) | 3.48944980 |
18 | Cerebral hypomyelination (HP:0006808) | 3.32126501 |
19 | Gaze-evoked nystagmus (HP:0000640) | 3.30013871 |
20 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.23105912 |
21 | Abnormality of the lower motor neuron (HP:0002366) | 3.22746215 |
22 | Cerebral inclusion bodies (HP:0100314) | 3.21332267 |
23 | Dysdiadochokinesis (HP:0002075) | 3.16916447 |
24 | Dysmetria (HP:0001310) | 3.15642490 |
25 | Depression (HP:0000716) | 3.13546147 |
26 | Impaired social interactions (HP:0000735) | 3.08100757 |
27 | Abnormal social behavior (HP:0012433) | 3.08100757 |
28 | Mutism (HP:0002300) | 3.01859272 |
29 | Truncal ataxia (HP:0002078) | 2.98231595 |
30 | Ankle clonus (HP:0011448) | 2.96457973 |
31 | Excessive salivation (HP:0003781) | 2.92801606 |
32 | Drooling (HP:0002307) | 2.92801606 |
33 | Akinesia (HP:0002304) | 2.91725064 |
34 | Neurofibrillary tangles (HP:0002185) | 2.90756274 |
35 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.86868668 |
36 | Tetraplegia (HP:0002445) | 2.82794195 |
37 | Anxiety (HP:0000739) | 2.80521316 |
38 | Abnormal eating behavior (HP:0100738) | 2.77817122 |
39 | Hemiparesis (HP:0001269) | 2.72312358 |
40 | Genetic anticipation (HP:0003743) | 2.70914779 |
41 | Papilledema (HP:0001085) | 2.70151379 |
42 | Sleep apnea (HP:0010535) | 2.69713936 |
43 | Postural instability (HP:0002172) | 2.65554329 |
44 | Abnormality of binocular vision (HP:0011514) | 2.63691069 |
45 | Diplopia (HP:0000651) | 2.63691069 |
46 | Epileptiform EEG discharges (HP:0011182) | 2.63317994 |
47 | Peripheral hypomyelination (HP:0007182) | 2.62732338 |
48 | Absent speech (HP:0001344) | 2.61832067 |
49 | Impaired smooth pursuit (HP:0007772) | 2.60265056 |
50 | Insidious onset (HP:0003587) | 2.57548575 |
51 | Termporal pattern (HP:0011008) | 2.57548575 |
52 | Urinary urgency (HP:0000012) | 2.56086815 |
53 | Stereotypic behavior (HP:0000733) | 2.55826604 |
54 | Clonus (HP:0002169) | 2.55182828 |
55 | Progressive inability to walk (HP:0002505) | 2.50970448 |
56 | EEG with generalized epileptiform discharges (HP:0011198) | 2.46993684 |
57 | Inability to walk (HP:0002540) | 2.43699598 |
58 | Status epilepticus (HP:0002133) | 2.43021493 |
59 | Scanning speech (HP:0002168) | 2.40912126 |
60 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.39927207 |
61 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.39927207 |
62 | Abnormality of the corticospinal tract (HP:0002492) | 2.38485151 |
63 | Generalized myoclonic seizures (HP:0002123) | 2.37754600 |
64 | Fetal akinesia sequence (HP:0001989) | 2.37260489 |
65 | Spastic gait (HP:0002064) | 2.36086928 |
66 | Bradykinesia (HP:0002067) | 2.34245560 |
67 | Intention tremor (HP:0002080) | 2.31082077 |
68 | Hypsarrhythmia (HP:0002521) | 2.28338748 |
69 | Amyotrophic lateral sclerosis (HP:0007354) | 2.27730634 |
70 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.25991327 |
71 | Delusions (HP:0000746) | 2.25302654 |
72 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.25147433 |
73 | Hemiplegia (HP:0002301) | 2.19989029 |
74 | Torticollis (HP:0000473) | 2.18255682 |
75 | Megalencephaly (HP:0001355) | 2.16749424 |
76 | Impaired vibratory sensation (HP:0002495) | 2.15454016 |
77 | CNS hypomyelination (HP:0003429) | 2.15098730 |
78 | Spastic tetraparesis (HP:0001285) | 2.15061189 |
79 | Focal dystonia (HP:0004373) | 2.13067979 |
80 | Ventricular fibrillation (HP:0001663) | 2.11421191 |
81 | Rigidity (HP:0002063) | 2.10546882 |
82 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.10313092 |
83 | Inappropriate behavior (HP:0000719) | 2.06301098 |
84 | Rapidly progressive (HP:0003678) | 2.05235311 |
85 | Lower limb muscle weakness (HP:0007340) | 2.04618472 |
86 | Dysmetric saccades (HP:0000641) | 2.02205841 |
87 | Obstructive sleep apnea (HP:0002870) | 2.01705576 |
88 | Agitation (HP:0000713) | 2.00650333 |
89 | Abnormality of salivation (HP:0100755) | 2.00267470 |
90 | Protruding tongue (HP:0010808) | 1.99347045 |
91 | Lower limb asymmetry (HP:0100559) | 1.96476996 |
92 | Choreoathetosis (HP:0001266) | 1.95482575 |
93 | Annular pancreas (HP:0001734) | 1.95424854 |
94 | Gait ataxia (HP:0002066) | 1.95145811 |
95 | Polyphagia (HP:0002591) | 1.94861318 |
96 | Apathy (HP:0000741) | 1.94259503 |
97 | Retinal dysplasia (HP:0007973) | 1.92012312 |
98 | Split foot (HP:0001839) | 1.91039119 |
99 | Incomplete penetrance (HP:0003829) | 1.90644720 |
100 | Pheochromocytoma (HP:0002666) | 1.89501032 |
101 | Spastic tetraplegia (HP:0002510) | 1.89437076 |
102 | Psychosis (HP:0000709) | 1.86500494 |
103 | Neuronal loss in central nervous system (HP:0002529) | 1.82485067 |
104 | Blue irides (HP:0000635) | 1.82406657 |
105 | Pointed chin (HP:0000307) | 1.80776186 |
106 | Thickened helices (HP:0000391) | 1.78627646 |
107 | Craniofacial dystonia (HP:0012179) | 1.78041716 |
108 | Hyperthyroidism (HP:0000836) | 1.76254580 |
109 | Unsteady gait (HP:0002317) | 1.74407200 |
110 | Hypoventilation (HP:0002791) | 1.73368941 |
111 | Gait imbalance (HP:0002141) | 1.70588391 |
112 | Insomnia (HP:0100785) | 1.70221433 |
113 | Lower limb amyotrophy (HP:0007210) | 1.69637209 |
114 | Diminished motivation (HP:0000745) | 1.69501884 |
115 | Paraplegia (HP:0010550) | 1.68591325 |
116 | Hypoplasia of the corpus callosum (HP:0002079) | 1.68262496 |
117 | Type II lissencephaly (HP:0007260) | 1.67812806 |
118 | Increased circulating renin level (HP:0000848) | 1.67795061 |
119 | Abnormality of saccadic eye movements (HP:0000570) | 1.66732037 |
120 | Limb dystonia (HP:0002451) | 1.66386220 |
121 | Specific learning disability (HP:0001328) | 1.65370645 |
122 | Spinal canal stenosis (HP:0003416) | 1.64207583 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 4.71272129 |
2 | EPHA4 | 4.55990625 |
3 | MAP3K9 | 3.99338393 |
4 | DAPK2 | 2.81436326 |
5 | MAP3K4 | 2.80694171 |
6 | RIPK4 | 2.76099352 |
7 | MINK1 | 2.65406323 |
8 | MARK1 | 2.62318221 |
9 | KSR2 | 2.38051571 |
10 | MAP2K7 | 2.36890747 |
11 | PAK6 | 2.26907170 |
12 | MAP3K12 | 2.10017676 |
13 | PLK2 | 1.93354694 |
14 | MAP2K4 | 1.92212490 |
15 | GRK5 | 1.88081160 |
16 | KSR1 | 1.85579331 |
17 | CASK | 1.85113581 |
18 | ARAF | 1.79978346 |
19 | DAPK1 | 1.79469330 |
20 | NTRK1 | 1.78552643 |
21 | NTRK2 | 1.76708471 |
22 | PNCK | 1.74989996 |
23 | PRPF4B | 1.74072381 |
24 | PRKD3 | 1.71109414 |
25 | CAMKK1 | 1.64843153 |
26 | SIK2 | 1.64453348 |
27 | MAP3K13 | 1.52782979 |
28 | CDK5 | 1.49548726 |
29 | CDK19 | 1.40685997 |
30 | TNIK | 1.27594903 |
31 | PRKCG | 1.27207694 |
32 | STK38 | 1.25953894 |
33 | PTK2B | 1.23169346 |
34 | MAPK13 | 1.19539148 |
35 | MAP3K2 | 1.15254123 |
36 | BMPR2 | 1.14011884 |
37 | FES | 1.09055461 |
38 | RAF1 | 1.05158383 |
39 | CAMK2A | 1.04526096 |
40 | TYRO3 | 1.03358569 |
41 | CAMKK2 | 1.00569449 |
42 | CAMK1 | 1.00199453 |
43 | LATS2 | 0.98851019 |
44 | UHMK1 | 0.93383031 |
45 | NEK6 | 0.91522756 |
46 | NME1 | 0.87004747 |
47 | CAMK2B | 0.86215543 |
48 | CDK18 | 0.86201842 |
49 | CDK14 | 0.85544748 |
50 | PHKG1 | 0.85125325 |
51 | PHKG2 | 0.85125325 |
52 | CDK15 | 0.84489239 |
53 | BRSK1 | 0.83193446 |
54 | MAP3K11 | 0.81899601 |
55 | RIPK1 | 0.81623190 |
56 | PKN1 | 0.81544033 |
57 | DYRK1A | 0.79188793 |
58 | PAK3 | 0.78416194 |
59 | STK11 | 0.76305895 |
60 | FGR | 0.74360362 |
61 | CDK11A | 0.73899089 |
62 | CCNB1 | 0.72472162 |
63 | RET | 0.72155766 |
64 | OXSR1 | 0.70406263 |
65 | LIMK1 | 0.69525490 |
66 | SGK494 | 0.66547371 |
67 | SGK223 | 0.66547371 |
68 | PDK1 | 0.64168337 |
69 | TAOK1 | 0.63787921 |
70 | SGK1 | 0.63698723 |
71 | CAMK1D | 0.63068559 |
72 | PRKCH | 0.62237318 |
73 | PDPK1 | 0.59996078 |
74 | MAP3K1 | 0.59828623 |
75 | PINK1 | 0.58488820 |
76 | MARK2 | 0.55928042 |
77 | DYRK2 | 0.55724343 |
78 | CSNK1G2 | 0.54242906 |
79 | TESK1 | 0.52449285 |
80 | ALK | 0.50735767 |
81 | CAMK2D | 0.50283127 |
82 | CAMK1G | 0.50089505 |
83 | DAPK3 | 0.48998837 |
84 | MAP2K1 | 0.48338327 |
85 | MOS | 0.48172928 |
86 | PRKCZ | 0.48147820 |
87 | PRKCE | 0.47998676 |
88 | SGK2 | 0.47086735 |
89 | MAP3K7 | 0.46623447 |
90 | FER | 0.46298124 |
91 | MAPK12 | 0.45232801 |
92 | CAMK4 | 0.44593303 |
93 | MAP3K6 | 0.44551048 |
94 | BRAF | 0.42617567 |
95 | CAMK2G | 0.42283574 |
96 | LMTK2 | 0.41597773 |
97 | GRK6 | 0.41333271 |
98 | RPS6KA3 | 0.40151794 |
99 | FYN | 0.38805460 |
100 | MAPK10 | 0.37749953 |
101 | SGK3 | 0.37589598 |
102 | ROCK2 | 0.35185272 |
103 | CSNK1E | 0.34799264 |
104 | TNK2 | 0.34506636 |
105 | DMPK | 0.34323352 |
106 | IRAK2 | 0.30562931 |
107 | ERBB2 | 0.29785221 |
108 | PRKACA | 0.29283551 |
109 | MAPK8 | 0.28165716 |
110 | CDC42BPA | 0.26274520 |
111 | CSNK1G3 | 0.26214986 |
112 | WNK1 | 0.26106108 |
113 | PRKCA | 0.26053453 |
114 | PRKCB | 0.25666643 |
115 | CSNK1D | 0.25574640 |
116 | GSK3B | 0.24939753 |
117 | PRKG1 | 0.24403584 |
118 | MUSK | 0.24214306 |
119 | FGFR2 | 0.23772424 |
120 | WNK3 | 0.21471448 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.80880226 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.24812665 |
3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.94241623 |
4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.79517528 |
5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.76462030 |
6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.72605629 |
7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.67495118 |
8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.55222360 |
9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.47867925 |
10 | Morphine addiction_Homo sapiens_hsa05032 | 2.38635458 |
11 | Salivary secretion_Homo sapiens_hsa04970 | 2.29580563 |
12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.27821878 |
13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.12376326 |
14 | Insulin secretion_Homo sapiens_hsa04911 | 1.96382260 |
15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.94076867 |
16 | Taste transduction_Homo sapiens_hsa04742 | 1.87831003 |
17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.84468137 |
18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.83384439 |
19 | Long-term depression_Homo sapiens_hsa04730 | 1.81706783 |
20 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.75605064 |
21 | Renin secretion_Homo sapiens_hsa04924 | 1.73057885 |
22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.66480157 |
23 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.65592372 |
24 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.65097811 |
25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.65089538 |
26 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.55379502 |
27 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.51279800 |
28 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.40178642 |
29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.37164835 |
30 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.35495429 |
31 | Gap junction_Homo sapiens_hsa04540 | 1.31516972 |
32 | Cocaine addiction_Homo sapiens_hsa05030 | 1.28389868 |
33 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.27688724 |
34 | Glioma_Homo sapiens_hsa05214 | 1.20749819 |
35 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.17322631 |
36 | Axon guidance_Homo sapiens_hsa04360 | 1.15600997 |
37 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.15472837 |
38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.10348245 |
39 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.09878939 |
40 | Melanogenesis_Homo sapiens_hsa04916 | 1.09359918 |
41 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.07905725 |
42 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.05578251 |
43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.04031577 |
44 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.01779778 |
45 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.01706912 |
46 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.01560478 |
47 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.00615148 |
48 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.99262180 |
49 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.96581144 |
50 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.94653468 |
51 | Phototransduction_Homo sapiens_hsa04744 | 0.92158591 |
52 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.91985824 |
53 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.87863724 |
54 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85462010 |
55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85251158 |
56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.82802684 |
57 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.80530993 |
58 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.79754383 |
59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.79026576 |
60 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.76501542 |
61 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.74279444 |
62 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69350150 |
63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68424044 |
64 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.67616189 |
65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64647917 |
66 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59409402 |
67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59291379 |
68 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57545414 |
69 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56952661 |
70 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.55183783 |
71 | Alzheimers disease_Homo sapiens_hsa05010 | 0.55161437 |
72 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54394246 |
73 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52439611 |
74 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49372958 |
75 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48643169 |
76 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.45698559 |
77 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.44427715 |
78 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.44273750 |
79 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.44183070 |
80 | Prion diseases_Homo sapiens_hsa05020 | 0.44012342 |
81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43506392 |
82 | Endocytosis_Homo sapiens_hsa04144 | 0.43354705 |
83 | Bile secretion_Homo sapiens_hsa04976 | 0.40979927 |
84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40620320 |
85 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.40332457 |
86 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.39897881 |
87 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.38962747 |
88 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.38732571 |
89 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38518676 |
90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37991667 |
91 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.36821434 |
92 | Alcoholism_Homo sapiens_hsa05034 | 0.36371269 |
93 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.36246504 |
94 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35055056 |
95 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.34582431 |
96 | Circadian rhythm_Homo sapiens_hsa04710 | 0.34282356 |
97 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.34052088 |
98 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.33234803 |
99 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.33211505 |
100 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.31894829 |
101 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.30449399 |
102 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.30105613 |
103 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.29792682 |
104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29506572 |
105 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.27394411 |
106 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.27340933 |
107 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.27321643 |
108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.26178288 |
109 | Parkinsons disease_Homo sapiens_hsa05012 | 0.25651931 |
110 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.25507237 |
111 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.23568629 |
112 | Tight junction_Homo sapiens_hsa04530 | 0.21607594 |
113 | Mineral absorption_Homo sapiens_hsa04978 | 0.20759888 |
114 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.18755509 |
115 | Histidine metabolism_Homo sapiens_hsa00340 | 0.18192801 |